BMN Blog

AUG 02
New Therapy for Malignant Brain Tumors

Tumor Treating Fields or TTF as it is more commonly known is a recently developed method by which malignant brain tumor cells are prevented from reproducing. Shelby Baptist Medical Center and Generations Radiotherapy & Oncology PC has begun therapy on its first patient using this entirely new approach in the treatment of malignant brain tumors with the Optune TTF system.

TTF works by delivering low level energy through the patient’s scalp which prevents brain tumor cells from reproducing. The energy alters the ability of sub-cellular structures known as microtubules to assemble, a necessary step in cancer cells’ attempts to divide and grow.

TTF therapy involves the patient wearing a series of electrodes on the scalp. The electrodes are attached to a compact, portable device that administers the alternating fields painlessly.  Other than the presence of the device, the patient is essentially unaware of therapy, and is able to continue at their pre-treatment level of functioning.

Data presented in April 2017 at the Annual Meeting of the American Association for Cancer Research demonstrates more than a doubling of survival in patients with glioblastoma (GBM) treated with TTF at four and five years, when compared to standard therapy.

Treatment with TTF can only be administered through physicians specially trained by Novocure in the administration of such therapy, and planning for the therapy involves coordination with the manufacturer’s specialists in treatment design.

Shelby Brookwood Baptist Medical Center is a part of the Brookwood Baptist Health System, the joint venture between Brookwood Medical Center and Baptist Health Systems.

Generations Radiotherapy & Oncology PC is a privately-owned radiotherapy center, founded on the Biblical principles of honesty, integrity, Christ-like compassion, and love for the people entrusted to our care. Generations is proud to serve the people of Shelby and Chilton counties and the surrounding areas.  We endeavor to provide treatment with forefront technology, delivered by people who value the uniqueness of every person we see.

Bookmark and Share


Post a Comment

Please login to post a comment.
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: